About immunitoAI
immunitoAI is a Healthcare company based in Bengaluru (India) founded in 2020 by Trisha Chatterjee and Aridni Shah. An AI-based platform for antibody discovery and therapeutics is developed. immunitoAI has raised $8 million across 6 funding rounds from investors including LetsVenture, Apex Group and Anicut Capital. The company has 17 employees. immunitoAI was last valued at $4.34 million in February 2024. Its chief executive, as recorded, is Aridni Shah. Its Indian entity Immunitoai Private Limited reported revenue of ₹5.8 Lakh. immunitoAI offers products and services including AI Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
immunitoAI was founded in 2020 in Bengaluru, India, within the biotechnology sector. An AI-driven platform is provided by the company for antibody discovery and therapeutic development. Antibody sequences are screened and ranked through imRANK to predict binding strength with antigens. Regions of antibodies are identified and mutated via imEVOLVE to enhance affinity. Operations are centered on computational tools for pharmaceutical applications in the region.
- Headquarters Bengaluru, India
- Employees 17
- Founders Trisha Chatterjee, Aridni Shah
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Website immunitoai.com
- Social LinkedIn X Facebook
- Legal Name Immunitoai Private Limited
- Date of Incorporation 28 Nov, 2020
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹5.8 Lakh
FY 2025 · -87% YoY
- Net Loss-₹1.17 Cr
FY 2025 · -2004% margin
- EBITDA-₹1.08 Cr
FY 2025 · -1845% margin
- Total Equity Funding$8M (USD)
in 6 rounds
- Latest Funding Round$6.1M (USD), Series A
Nov 2025
- InvestorsLetsVenture
& 22 more
- Employee Count17
Associated legal entities of immunitoAI
immunitoAI operates through Immunitoai Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Immunitoai Private Limited CIN U72900KA2020PTC141607 | Active | 28 Nov 2020 | Bangalore, Karnataka | ₹0.1 Cr | 17 | 2 | View details |
Products & Services of immunitoAI
immunitoAI offers a comprehensive portfolio of products and services, including AI Platform.
Generates novel antibodies using AI for therapeutic development.
Funding Insights of immunitoAI
immunitoAI has successfully raised a total of $8M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $6.1 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8M
- Total Rounds 6
- Last Round Series A — $6.1M
- First Round $1M
(Mar 2021)
- Investors Count 23
All 6 funding rounds of immunitoAI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2025 | $6.1M | Series A | – | – | – |
| Oct 2025 | $48,466 | Series A | – | – | |
| Aug 2025 | $56,450 | Seed | – | C-CAMP | – |
| Jan 2025 | $341,066 | Seed | – | Aneesh Venkatadri | |
| Feb 2024 | $452,261 | Seed | $4.34M | – | |
| Mar 2021 | $1M | Seed | – | pi Ventures |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2024 | $4.34M | •••••••• |
Last known valuation $4.34M (Feb 2024). 23 investors in total: 12 institutional and 11 angel.
Investors in immunitoAI
immunitoAI has secured backing from 23 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include LetsVenture, Apex Group and Anicut Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment services in private credit, seed funds, growth equity, and late-stage equity for businesses in India. | 2015 | anicutcapital.com | Chennai, India | |
Deep-tech venture capital investments in early-stage companies. | 2016 | piventures.in | Bengaluru, India | |
Early-stage technology companies are invested in by Jj Family Office. | Mumbai, India | |||
Provider of a program turning individuals into funded technology company founders | joinef.com | London, United Kingdom | ||
Private equity firm focused on multiple sectors | Ebene City, Mauritius | |||
Private equity firm focused on multiple sectors | Mumbai, India | |||
| ccamp.res.in | ||||
| wefoundercircle.com | ||||
Online platform that connects startup founders with accredited investors, enabling early-stage fundraising and investment opportunities for private market growth | 2013 | letsventure.com | Bengaluru, India | |
Apex Group is recognized as a single-source financial solution provider. | 2003 | apexgroup.com | Bermuda |
Investor details for immunitoAI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Immunitoai Private Limited (immunitoAI)
Immunitoai Private Limited is the primary company behind immunitoAI. The board of Immunitoai Private Limited currently have 2 directors; the longest-serving is Aridni Shah, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aridni Shah DIN 08976859 | Director | 28 Nov 2020 | 5 yrs 11 mo | Immunitoai Private Limited |
| Trisha Chatterjee DIN 08976860 | Director | 28 Nov 2020 | 5 yrs 11 mo | Immunitoai Private Limited |
People of immunitoAI
8 people are tracked at immunitoAI (2 in leadership, 6 in team); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CTO | Leadership | |
| Co-Founder & CEO | Leadership | |
Bhawna Burdak | Senior Scientist | Team |
Sanchez Eugene | Research Associate | Team |
Devendra Singh Chundawat | Research Software Engineer | Team |
Abhishek Jhade | Senior Product Engineer | Team |
Anwesha Paul | Research Associate | Team |
Abhishek Jain | Software Engineer | Team |
Complete people profiles for immunitoAI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of immunitoAI
Figures of Immunitoai Private Limited, the primary company behind immunitoAI, for FY 2025. Revenue was ₹5.8 Lakh (-87% year on year). Net loss was -₹1.17 Cr (-2004% margin). EBITDA was -₹1.08 Cr (-1845% margin). Revenue has grown at a compounded annual rate of +38% over three years.
- ₹5.8 LakhRevenue · FY 2025 · -87% YoY
- -₹1.17 CrNet loss · -2004% margin
- -₹1.08 CrEBITDA · -1845% margin
- ₹2.5 LakhPaid-up capital
- 17Employees (provident fund records)
- +38%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Immunitoai Private Limited are on its company page.
Detailed financial statements for immunitoAI
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of immunitoAI
4 dated milestones of immunitoAI across 5 years, from founding to its latest funding, stage changes and deals.
- Founded immunitoAI is founded.
- Funding First funding round of $1.0M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $6.1M.
Web traffic of immunitoAI
The website of immunitoAI (immunitoai.com) receives about 9.5K visits a month.
- Monthly visits9.5K
▼ 20.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Immunitoai
Complete news archive for immunitoAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about immunitoAI
immunitoAI was founded in 2020 and raised its 1st funding round 1 year after it was founded.
immunitoAI is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Aridni Shah is the CEO of immunitoAI, as recorded in our data. They have also founded this company.
immunitoAI is a funded company, having raised a total of $8M across 6 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Mar 2021.
immunitoAI has 17 employees.
The primary company behind immunitoAI, Immunitoai Private Limited, reported revenue of ₹5.8 Lakh for FY 2025, down 87% year on year.
immunitoAI was founded in 2020 in Bengaluru, India, within the biotechnology sector. An AI-driven platform is provided by the company for antibody discovery and therapeutic development. Antibody sequences are screened and ranked through imRANK to predict binding strength with antigens. Regions of antibodies are identified and mutated via imEVOLVE to enhance affinity. Operations are centered on computational tools for pharmaceutical applications in the region.
immunitoAI offers AI Platform.
immunitoAI has 23 investors. Key investors include LetsVenture, Apex Group, Anicut Capital, pi Ventures, and Jj Family Office.
The valuation of immunitoAI is $4.34M as of Feb 2024.
immunitoAI operates through Immunitoai Private Limited.
The legal entities of immunitoAI currently have 2 directors, including Aridni Shah, Trisha Chatterjee.